User profiles for Jason D. Goldman
 | Jason D. Goldman, MD, MPHSwedish Medical Center, Fred Hutch, University of Washington Verified email at uw.edu Cited by 9728 |
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo …
…, R Liao, MLB Piruzeli, JD Goldman… - The lancet Respiratory …, 2021 - thelancet.com
Background Baricitinib is an oral selective Janus kinase 1/2 inhibitor with known anti-inflammatory
properties. This study evaluates the efficacy and safety of baricitinib in combination …
properties. This study evaluates the efficacy and safety of baricitinib in combination …
[PDF][PDF] Multiple early factors anticipate post-acute COVID-19 sequelae
Post-acute sequelae of COVID-19 (PASC) represent an emerging global crisis. However,
quantifiable risk factors for PASC and their biological associations are poorly resolved. We …
quantifiable risk factors for PASC and their biological associations are poorly resolved. We …
Covid-19 in critically ill patients in the Seattle region—case series
…, A Gerbino, CR Dale, JD Goldman… - … England Journal of …, 2020 - Mass Medical Soc
Background Community transmission of coronavirus 2019 (Covid-19) was detected in the
state of Washington in February 2020. Methods We identified patients from nine Seattle-area …
state of Washington in February 2020. Methods We identified patients from nine Seattle-area …
Remdesivir for 5 or 10 days in patients with severe Covid-19
Background Remdesivir is an RNA polymerase inhibitor with potent antiviral activity in vitro
and efficacy in animal models of coronavirus disease 2019 (Covid-19). Methods We …
and efficacy in animal models of coronavirus disease 2019 (Covid-19). Methods We …
[PDF][PDF] Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19
We present an integrated analysis of the clinical measurements, immune cells, and plasma
multi-omics of 139 COVID-19 patients representing all levels of disease severity, from serial …
multi-omics of 139 COVID-19 patients representing all levels of disease severity, from serial …
Coronavirus disease 2019 in solid organ transplant: a multicenter cohort study
…, H Neumann, A Badami, JD Goldman… - Clinical Infectious …, 2021 - academic.oup.com
Background The coronavirus disease 2019 (COVID-19) pandemic has led to significant
reductions in transplantation, motivated in part by concerns of disproportionately more severe …
reductions in transplantation, motivated in part by concerns of disproportionately more severe …
Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or …
…, R Liao, MLB Piruzeli, JD Goldman… - The Lancet …, 2022 - thelancet.com
Background The oral, selective Janus kinase 1/2 inhibitor baricitinib has shown efficacy in
studies of hospitalised adults with COVID-19. COV-BARRIER (NCT04421027) was a …
studies of hospitalised adults with COVID-19. COV-BARRIER (NCT04421027) was a …
[HTML][HTML] Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels
T cells are involved in the early identification and clearance of viral infections and also
support the development of antibodies by B cells. This central role for T cells makes them a …
support the development of antibodies by B cells. This central role for T cells makes them a …
Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19
A better understanding of the metabolic alterations in immune cells during severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may elucidate the wide diversity of …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may elucidate the wide diversity of …
[HTML][HTML] A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2
We describe the establishment and current content of the ImmuneCODE™ database, which
includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects …
includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects …
